Navigation Links
GeoVax Labs, Inc. Second Quarter Financial Results and Operational Update
Date:8/19/2007

(R) cell

lines (avian embryonic derived stem cell lines) for the production of

GeoVax's MVA (Modified Vaccinia Ankara) based HIV/AIDS vaccines.

Results obtained from Vivalis and GeoVax demonstrated that EBx(R) cell

technology is possibly a more economical alternative to chicken

embryonic fibroblasts (CEFs) for the replication of GeoVax specific

recombinant MVA based AIDS vaccines. Simultaneously, GeoVax's promising

results in preclinical trials as well as encouraging and positive

immune response data from two ongoing human trials provided the impetus

for accelerating clinical evaluations of GeoVax's vaccines and for

considering the EBx(R) cell platform in industrial vaccine production.

Vivalis and GeoVax collaborations focus on scaling-up MVA based

HIV/AIDS vaccine production processes in EBx(R) cells. In addition,

Vivalis plans preparation of an EBx(R) platform Biological Master File

for filing with the FDA. In parallel, GeoVax is evaluating plans for an

immunogenicity comparability study of GeoVax's MVA based HIV/AIDS

vaccines produced in CEFs and those produced in EBx(R) cells. This

information may be presented in a pre-IND meeting with the FDA

concerning potential use of this cell line.

Management Commentary

Donald Hildebrand, Chief Executive Officer of GeoVax, commented, "Recent developments at GeoVax encourage and excite us as we continue working toward our ultimate goal of making available a safe and effective vaccine for the prevention of AIDS. We are particularly encouraged by the recent accelerated start date of our two new human clinical trials, resulting primarily from the excellent safety and anti-HIV immune response results obtained to date from our ongoing 1/10th and full dose vaccine trials. We are also pleased with the positive response to our progress at GeoVax as reflected by
'/>"/>

SOURCE GeoVax Labs, Inc.

Copyright©2007 PR Newswire.

Page: 1 2 3 4 5 6

Related biology technology :

1. Use of the PROTEAN Plus Dodeca Cell for Second-Dimension SDS-PAGE, Rev A
2. In Vitro Measurement of the Second Messenger cAMP: RIA vs. FlashPlate
3. CIOs looking to hire more IT workers in second quarter
4. DNASTAR catches second wave of sequencing
5. 9 tips for making 90 seconds count in an investment pitch
6. City of Hope adds second TomoTherapy system
7. UW-Madison hybrid-vehicle team places second nationally
8. Just one nanosecond: Clocking events at the nanoscale
9. MATCs new computer security program gears up for second semester
10. Weather Central launches second satellite
11. nPoint Secures Second Round of Funding
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/15/2014)... January 15, 2014 The Microcompetition with Foreign ... disease. One of these latent viruses is the Epstein Barr ... (RA). Rheumatoid arthritis (RA) is a chronic inflammatory disease that ... study found that RA patients have high concentrations of EBV ...
(Date:1/15/2014)... Freeslate, Inc ., the leading ... Lupin Limited, one of India’s top five pharmaceutical companies, ... System for high throughput solid form screening. ... a wide range of quality, affordable generic and branded ...
(Date:1/14/2014)... Date: Friday, April 11, 2014 , Time: 6 p.m. ... Road, Warrington, Pa. , Details: The Hepatitis B ... a cure for hepatitis B and improving the quality of ... Ball on Friday, April 11 at Warrington Country Club in ...
(Date:1/14/2014)... , Jan. 14, 2014  3D Communications, a leading provider of strategic ... business, and media events in the United States ... associate Virginia Cox , JD, is returning to the firm,s ... Cox re-joins 3D after more than two years of service ...
Breaking Biology Technology:Study: Rheumatoid Arthritis (RA) Patients Have EBV; The CBCD Says this is Consistent with Microcompetition 2Study: Rheumatoid Arthritis (RA) Patients Have EBV; The CBCD Says this is Consistent with Microcompetition 3Lupin Selects Freeslate’s CM Protégé PharmD System to Accelerate Polymorph Screening for Drug Development 2Lupin Selects Freeslate’s CM Protégé PharmD System to Accelerate Polymorph Screening for Drug Development 3Hepatitis B Foundation to Host Annual Crystal Ball Gala 2Former FDA Associate Commissioner Returns To 3D Communications 2
... of enzymes routinely used to synthesizing some of nature's most ... new way to expand on nature's chemical creativity to make ... 1) in the journal Science , a team led ... the University of Wisconsin-Madison , describes the discovery of ...
... the new darling of Wall Street. In the past ... private equity firms, venture capital firms, and hedge funds. ... trading multiples in excess of $5 per gallon of ... EBITDA, and 1,000x trailing four quarters of net income. ...
... - When it comes to attracting venture capital, Wisconsin has ... Investors on the East and West coasts have basically stuck ... in the Heartland, with the exception of a few states ... have been signs that a few flights ferrying venture capitalists ...
Cached Biology Technology:UW finds new path to anti-cancer agents 2UW finds new path to anti-cancer agents 3Ethanol producers are at a crossroads 2Ethanol producers are at a crossroads 3Ethanol producers are at a crossroads 4Ethanol producers are at a crossroads 5Ethanol producers are at a crossroads 6That blip on the national venture capital radar screen may be Wisconsin 2That blip on the national venture capital radar screen may be Wisconsin 3
(Date:4/17/2014)... N.M. A credit-card-sized anthrax detection cartridge developed at ... business makes testing safer, easier, faster and cheaper. ... anthrax, is commonly found in soils all over the ... in both humans and animals. The bacteria can survive ... B. anthracis may occur through skin contact, ...
(Date:4/17/2014)... in German . ... they also provide us with a continuous stream of information ... or sit still in a car the world glides ... retinas. Seemingly without effort, our brain calculates self-motion from this ... and a steady gaze during our own movements. Together with ...
(Date:4/17/2014)... hydrogen sulfide in order to properly multiply and form ... Center for Craniofacial Molecular Biology at the Herman Ostrow ... principal investigator on the project, said the presence of ... of calcium ions. The essential ions activate a chain ... creation of new bone tissue, and keeps the breakdown ...
Breaking Biology News(10 mins):Pocket-sized anthrax detector aids global agriculture 2Pocket-sized anthrax detector aids global agriculture 3How vision makes sure that little fish do not get carried away 2How vision makes sure that little fish do not get carried away 3How vision makes sure that little fish do not get carried away 4
... it may sound like an oxymoron, a University of Iowa ... skull from a "pygmy-sized" giant panda -- the earliest-known ancestor ... some two million years ago. , The ancestor of today's ... Ciochon, UI professor of anthropology. Ciochon (pronounced schuh-HON) is a ...
... the link between the way an animal moves and the dimensions ... semicircular canals of the inner ear on each side of the ... on 26 June in the print edition of the Proceedings of ... edition during the week of 18 to 22 June. , ...
... cells that is altered by genetic mutations recently identified in ... mutations affect cellular function and could provide a target for ... a team of Emory University scientists will be published June ... journal. , Parkinson disease is a degenerative disorder ...
Cached Biology News:UI anthropologist, colleagues discover remains of earliest giant panda 2Reconstructing the biology of extinct species: A new approach 2Researchers identify protein pathway involved in Parkinson disease development 2
Anti-TWIK-1 Immunogen: Purified peptide from amino acids 53-69 of human TWIK-1 (Accession number O00180)....
Monoclonal 8C2.1 is specific for Bunyavirus G1 as tested by neutralization, immunoprecipitation and immunobinding assays....
BI-1 Polyclonal Antibody Storage Temperature: -20C Shipping: gel pack Shelf-Life: 12 months...
...
Biology Products: